Omeros Corporation (Nasdaq: OMER) announced that the National Institute on drug Abuse (NIDA) is providing support for the Company’s Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers…

Omeros Announces National Institute On drug Abuse’s Support For Phase 2 Clinical Study In Addiction Program



Rox PharmacySponsored by RoxPharmacy.com - Online Pharmacy, an pharmacy online supplies more than 500 quality generic products, free prescription, worldwide shipping.
xanax

Online Canadian Pharmacy canada pharmacy
Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • LinkedIn
  • Live
  • StumbleUpon
  • Yahoo! Buzz
  • Slashdot
  • Technorati
  • MSN Reporter

Related posts:

  1. Catalyst Pharmaceutical Partners And The National Institute On Drug Abuse Plan To Initiate U.S. Phase II(b) Clinical Trial For Cocaine Addiction
  2. Advaxis Announces Phase II Trial Collaboration With The National Cancer Institute
  3. America’s Silent Crisis: Addiction — Downturn Fuels Rising Drug And Alcohol Abuse, Phoenix House Study Reveals